Suven Life Sciences Limited Stock NSE India S.E.
Equities
SUVEN
INE495B01038
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113.8 INR | +0.84% | +0.13% | +40.87% |
Sales 2022 | 120M 1.43M | Sales 2023 | 136M 1.63M | Capitalization | 10.57B 127M |
---|---|---|---|---|---|
Net income 2022 | -1.22B -14.64M | Net income 2023 | -1.18B -14.19M | EV / Sales 2022 | 109 x |
Net cash position 2022 | 472M 5.67M | Net cash position 2023 | 2.27B 27.21M | EV / Sales 2023 | 61.1 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-7.31
x | Employees | 132 |
Yield 2022 |
1.08% | Yield 2023 |
-
| Free-Float | 28.95% |
Latest transcript on Suven Life Sciences Limited
1 day | +0.84% | ||
1 week | +0.13% | ||
Current month | +2.99% | ||
1 month | +5.52% | ||
3 months | +4.45% | ||
6 months | +48.98% | ||
Current year | +40.87% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 89-03-08 | |
M. Mohan Kumar
DFI | Director of Finance/CFO | - | 20-01-09 |
Shrenik Soni
CMP | Compliance Officer | - | 20-01-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 89-03-08 | |
Sudha Rani Jasti
FOU | Founder | 70 | 89-03-08 |
Director/Board Member | 70 | 10-04-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 113.8 | +0.84% | 221,598 |
24-05-02 | 112.8 | +2.13% | 206,370 |
24-04-30 | 110.4 | -0.81% | 109,193 |
24-04-29 | 111.4 | -0.09% | 147,183 |
24-04-26 | 111.4 | -1.89% | 169,884 |
Delayed Quote NSE India S.E., May 03, 2024 at 07:43 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- SUVEN Stock
- SUVEN Stock